While IL-10 is known to be anti-inflammatory, IL-22 fulfills a proinflammatory role in many different tissues and is involved in numerous diseases, including inflammatory bowel disease (IBD), psoriasis, and cancer, making it an interesting target or potential therapeutic. This evidence concerns the gene IL22 and inflammatory bowel disease.